CPAP vs BiPAP: What Your Facility Actually Needs, Scenario by Scenario

"Which should my facility buy—CPAP or BiPAP?" I get this question more than any other. I've seen it come up at regional hospitals like Hamilton Medical Center in Georgia, in outpatient clinics throughout the Reno, NV area, and in sleep labs preparing to open their doors. My answer is always the same: it depends.

I work as a quality and brand compliance manager at Hamilton Medical. I review equipment documentation before it reaches customers—roughly 200+ device configurations a year. Most of the problems I catch aren't manufacturing defects; they're spec mismatches. A device that's perfect for one patient population is the wrong choice for another. CPAP vs BiPAP is the clearest example I know.

When I first started reviewing respiratory devices, I assumed this was a budget conversation. BiPAP costs more, so it must be "better." Three years and a few hundred spec sheets later, I learned it's actually a diagnosis conversation. You can't choose between CPAP and BiPAP until you know what a patient's lungs are doing overnight.

What CPAP and BiPAP Actually Do

CPAP (continuous positive airway pressure) delivers one continuous pressure—or rather, one prescribed pressure—through the entire breathing cycle. Its job is to splint the airway open. That makes it the default treatment for obstructive sleep apnea (OSA), where the airway collapses during sleep but the patient's drive to breathe is otherwise normal.

BiPAP—or rather, bilevel positive airway pressure, since "BiPAP" is technically a Philips Respironics trademark—delivers two pressures: a higher inspiratory pressure (IPAP) and a lower expiratory pressure (EPAP). The difference between the two is pressure support. That support is what helps patients move more air. It's not a "more advanced CPAP." It's a different therapeutic mechanism.

This matters for purchasing because vendors blur the line. A CPAP with exhalation pressure relief is not a BiPAP. I've seen spec sheets where "bilevel mode" meant a softer exhale, not true IPAP/EPAP support. The most frustrating part? The mistakes keep repeating. Documentation you'd expect to be unambiguous—well, it isn't.

Scenario A: Uncomplicated OSA Patients → CPAP

If your population is straightforward OSA—no daytime hypercapnia, no COPD, no obesity hypoventilation—CPAP is the appropriate choice. That's consistent with the American Academy of Sleep Medicine's (AASM) 2019 clinical practice guideline, which recommends positive airway pressure therapy for adults with OSA.

What to check in the spec sheet:

• Auto-adjusting vs. fixed pressure. If your patients haven't had a full in-lab titration, an auto-CPAP reduces the chance of therapy failure. In 2023, I reviewed a clinic's PAP purchase where the main rework problem was fixed-pressure devices prescribed without titration.
• Data recording. Payers and accreditation bodies increasingly want compliance data. A device without meaningful data logging saves money upfront and costs you all year.
• Mask and accessory compatibility. I've seen a clinic standardize on a mask system that didn't fit the tubing of their chosen device. Check the ecosystem, not just the device.

Pricing for basic home CPAP devices was roughly $500 to $1,500 per unit as of January 2025—don't quote me on the exact figures, and verify current pricing with distributors, because rates shift quarterly.

Scenario B: Patients Need Ventilatory Support → BiPAP

This is the scenario that gets mispositioned most often. If your patients have obesity hypoventilation syndrome (OHS), COPD with chronic hypercapnia, OSA with hypoventilation, or neuromuscular disease, a CPAP won't do the job. These patients don't just stop breathing—they don't ventilate enough, so CO2 rises. CPAP splints the airway open; it doesn't meaningfully improve ventilation. The pressure support in BiPAP does.

The AASM's clinical guidance on OHS (2019) treats positive airway pressure as central to long-term management. When the problem is ventilation rather than airway patency, NIV—bilevel PAP—is the modality that provides the pressure support you need. The GOLD 2024 report similarly identifies home NIV as an option for stable COPD patients with chronic hypercapnia. In plain language: this is a clinical decision, not a "let's save money by buying the cheaper device" decision.

A cautionary example from 2023: a facility asked us to review why their therapy program was underperforming. They'd standardized on fixed CPAP devices for every sleep-disordered breathing patient to save about $200 per unit. Roughly 12% of those patients came back with persistent hypercapnia symptoms and eventually needed bilevel devices. The initial savings disappeared in replacement costs, additional appointments, and one hospital admission.

What to check in the spec sheet:

• IPAP/EPAP pressure range. Some travel-sized bilevel devices have limited IPAP ceilings. Match the range to your patient population's needs.
• Backup rate (timed mode). If your patients have central sleep apnea or hypoventilation, a device without a backup rate can under-ventilate them at night.
• Volume-assured modes (e.g., AVAPS). Not a must-have for everyone, but valuable when you need to guarantee consistent tidal volumes.

Scenario C: Acute Care or High-Acuity Patients → A Full NIV-Capable Ventilator

If you're a hospital unit delivering NIV for acute respiratory failure—emergency department, step-down, respiratory care unit—the conversation changes. Home BiPAP devices are engineered for chronic, unattended use at night. They're leak-tolerant and log compliance data. But they typically lack the precise tidal volume delivery, FiO2 control, and alarm architecture an acute care patient needs.

This is also the scenario where you need a device that can move from non-invasive to invasive ventilation if the patient deteriorates. A home PAP device can't make that transition.

At Hamilton Medical, critical-care ventilators are our focus. I'll be upfront: we don't make home CPAP machines. The reason is exactly this distinction. A patient in acute respiratory failure isn't a "home PAP" scenario. A full ventilator with an NIV mode provides leak compensation, real-time volume monitoring, and alarms—things that matter when care is active, not optional.

The surprise in my work wasn't that advanced ventilators have more features. It was how often the expensive-vs-basic mismatch ran in both directions. Facilities bought a home BiPAP for acute care when they needed a ventilator. Others bought a ventilator when a home CPAP—or rather, a $700 data-capable CPAP—was clinically sufficient. Both directions cost the organization money.

How to Know Which Scenario You're In

Run through these questions, in order:

1. What's the primary diagnosis in your patient population? OHS, COPD, or neuromuscular disease points to Scenario B. Uncomplicated OSA points to Scenario A. Acute respiratory failure points to Scenario C.
2. Is anyone hypercapnic? Check blood gas data. Elevated daytime CO2 or suspected nocturnal hypoventilation immediately removes you from Scenario A.
3. Does this equipment have to handle emergencies? If the unit receives undifferentiated acute patients, the ventilator question is real.
4. Who reads the data at 2 a.m.? A BiPAP with a backup rate requires staff who can interpret alarms and trend data. If the team can't, that's a training investment, not a device feature.
5. What's the full consumable ecosystem? Masks, circuits, filters, batteries, data cards—verify availability before you sign the PO, not after.

To be fair, I understand why facilities try to standardize on a single device. Managing multiple device types is hard, and training costs are real. But a standardized device that doesn't fit half your patient population isn't standardization—it's risk.

This is the prevention-over-cure principle I apply in quality work every day:

Five minutes of specification verification beats five months of therapy failure.

Every problem in the scenarios above was visible on a spec sheet before purchase.

The Same Discipline Applies to All Medical Equipment

This isn't a respiratory-only problem. I review hearing aid programmers with the same lens: software update path, probe-tube compatibility, calibration traceability. Physiotherapy equipment gets the same scrutiny—service support and calibration history matter more than the headline feature. When we specify a device, the question is never "does this look advanced?" It's "does this match the patient population and the staff's skill level?"

Bottom Line

CPAP vs BiPAP is not a budget question. It's a patient question.

Uncomplicated OSA → CPAP, preferably a data-capable auto-device. Hypercapnia or suspected hypoventilation → BiPAP, with a backup rate where indicated. Acute care → a full NIV-capable ventilator.

Start with your patient population, verify the specs, and check the support ecosystem before you sign anything. Prevention is cheaper than correction—in quality review, in procurement, and in patient outcomes.